ClinicalTrials.gov
ClinicalTrials.gov Menu

Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants (COSTAN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01706107
Recruitment Status : Terminated (Due to on-going enrollment challenges)
First Posted : October 15, 2012
Last Update Posted : January 12, 2016
Sponsor:
Information provided by (Responsible Party):
Biogen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : October 2017
  Estimated Study Completion Date : January 2018